Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Novel 5-HT4 agonist in development at Yoshitomi for GI motility disorders

April 1, 1998

Toyama's T-593 associated with improved quality of ulcer healing compared to other H2 blockers

April 1, 1998

Taisho's H2 antagonist displays potent antiulcer activity in preclinical models

March 31, 1998

KW-5617: a calmodulin inhibitor with antidiarrheal activity

March 31, 1998

Glaxo Wellcome files for European approval of lamivudine in HBV

March 26, 1998

IL-10 in clinical testing for multiple indications at Schering-Plough

March 26, 1998

Phase II trial begins with rPAF-AH in pancreatitis

March 17, 1998

Intercardia to license IBD drug

March 13, 1998

Novel gastrointestinal agents in early development at Dainippon

March 12, 1998

New cisapride formulation introduced in U.K.

March 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...